VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
BTSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BTSGBrightSpring Health Services, Inc. Common Stock
$61.71$12.1B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBTSGBalance Sheet

BrightSpring Health Services, Inc. Common Stock (BTSG) Balance Sheet

7Y historyFree accessUpdated daily

Debt-to-equity improved to 1.17 in 2026Q2 from 1.83 in 2024Q1, yet total debt of $2.4B and goodwill of $2.5B (42% of assets) highlight leverage and impairment risks.

BTSG Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets2.47B2.89B1.89B1.46B1.34B1.18B1.29B870.68M
Cash & Short-Term Investments550.38M88.37M61.25M13.07M13.63M46.73M262M18.3M
Cash Only550.38M88.37M61.25M13.07M13.63M46.73M262M18.3M
Short-Term Investments00000000
Accounts Receivable1.31B1.07B1.15B1.01B868.35M805M700.84M622.28M
Days Sales Outstanding29.7930.3137.2341.841.0543.8745.8450.19
Inventory575.01M815.18M640.57M402.78M430.52M299.22M300.06M198.47M
Days Inventory Outstanding18.7726.1224.1619.8924.6820.0424.1719.63
Other Current Assets20.4M899.01M24.59M13.19M13.51M12.66M16.41M23.37M
Total Non-Current Assets3.52B3.52B4.03B4.08B4.1B4.33B3.25B2.95B
Property, Plant & Equipment380.84M376.32M500.03M513.35M475.27M524.64M450.71M432.55M
Fixed Asset Turnover39.17x34.31x22.53x17.19x16.24x12.77x12.38x10.46x
Goodwill2.54B2.55B2.67B2.61B2.58B2.66B1.67B1.41B
Intangible Assets468.31M557.55M811.48M881.48M975.86M1.11B1.1B1.07B
Long-Term Investments55.74M8.2M670K720K736K2.66M2.48M2.37M
Other Non-Current Assets107.69M31.51M43.8M72.12M68.93M35.78M32.22M34.56M
Total Assets5.99B6.41B5.93B5.53B5.44B5.51B4.54B3.82B
Asset Turnover2.33x2.01x1.90x1.60x1.42x1.21x1.23x1.19x
Asset Growth %19.75%8.22%7.11%1.68%-1.31%21.41%18.96%-
Total Current Liabilities1.56B1.85B1.43B1.25B932.51M892.16M742.79M621.97M
Accounts Payable1.09B1.22B941.29M641.61M526.92M408.11M355.75M252.75M
Days Payables Outstanding31.5639.0235.531.6830.2127.3328.6524.99
Short-Term Debt41.45M52.34M48.73M32.27M30.41M40.54M22.5M18.48M
Deferred Revenue (Current)39.6M9.04M11M30.85M29.04M10.49M22.76M3.31M
Other Current Liabilities-13.08M297.19M98.84M118.14M80.73M95.87M16.18M14.19M
Current Ratio1.59x1.57x1.33x1.17x1.44x1.32x1.74x1.40x
Quick Ratio1.22x1.12x0.88x0.84x0.98x0.99x1.33x1.08x
Cash Conversion Cycle16.9917.4125.8930.0135.5336.5741.3544.83
Total Non-Current Liabilities2.37B2.68B2.85B3.67B3.72B3.82B3.06B2.49B
Long-Term Debt2.15B2.46B2.56B3.33B3.36B3.39B2.67B2.16B
Capital Lease Obligations584.2M149.96M212.6M224.18M204.91M252.09M211.95M190.15M
Deferred Tax Liabilities18.42M6.18M023.67M79.39M98.16M121.64M65.68M
Other Non-Current Liabilities76.61M66.56M71.76M91.94M75.94M77.04M57.98M65.46M
Total Liabilities3.93B4.53B4.27B4.92B4.66B4.71B3.81B3.11B
Total Debt2.39B2.71B2.9B3.67B3.68B3.77B2.97B2.44B
Net Debt1.84B2.62B2.84B3.66B3.66B3.72B2.71B2.43B
Debt / Equity1.16x1.44x1.76x5.99x4.69x4.71x4.04x3.44x
Debt / EBITDA3.74x5.89x7.07x10.50x9.39x8.70x8.58x11.20x
Net Debt / EBITDA2.88x5.70x6.92x10.46x9.35x8.59x7.82x11.12x
Interest Coverage3.14x1.88x0.85x0.45x0.80x1.42x1.19x0.38x
Total Equity2.06B1.89B1.65B612.55M784.08M800.46M735.38M710.23M
Equity Growth %62.31%14.22%169.63%-21.88%-2.05%8.85%3.54%-
Book Value per Share9.348.588.563.584.584.684.304.15
Total Shareholders' Equity2.05B1.88B1.65B584.74M754.78M774.82M704.98M656.87M
Common Stock1.98M1.92M1.74M1.18M1.18M1.18M745.17M745.88M
Retained Earnings38.43M-74.65M-222.16M-200.32M-45.72M971K-51.75M-94.28M
Treasury Stock00000000
Accumulated OCI4.18M-6.69M1.42M12.54M21.19M217K185K132K
Minority Interest9.48M11.3M3.73M27.81M29.31M25.65M30.39M53.36M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Leverage and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Easing as Equity Builds

Debt-to-equity fell from 1.83 in 2024Q1 to 1.17 in 2026Q2, while retained earnings turned positive at $38.4M, according to recent SEC filings, indicating a strengthening equity base.

The balance sheet is deleveraging steadily, with total debt reduced from $2.9B to $2.4B over the period, while equity expanded from $1.6B to $2.0B. This trend suggests that the company is using cash flow to pay down debt and retain earnings, a positive shift from the prior loss-making quarters. However, the absolute debt level remains high relative to equity, and the improvement is partly due to the low base of equity, so the trajectory is encouraging but not yet robust.

High Leverage Persists Despite Reduction

Total debt of $2.4B in 2026Q2 still represents 40% of total assets, with a debt-to-equity ratio of 1.17, as reported in financial statements, indicating significant financial risk.

Although the D/E ratio has improved from 1.83 to 1.17, the company remains highly leveraged, especially when compared to peers like Addus HomeCare (D/E 0.19) and LifeStance (0.13). The absolute debt level is substantial relative to the company's equity base, and with net margins of only 1.5%, interest coverage is likely thin. This leverage appears to be a legacy of the PharMerica acquisition and other roll-up strategies, and while it is being reduced, the pace may be slow given the modest profitability.

Goodwill Dominates Asset Base

Goodwill of $2.5B accounts for 42% of total assets in 2026Q2, as per the balance sheet, while net PPE is only $380.8M, underscoring the asset-light, acquisition-driven model.

The asset mix is heavily weighted toward intangible assets, with goodwill alone exceeding the entire equity base. This suggests that the company's value is tied to acquired businesses, and any impairment could significantly erode equity. The low PPE relative to revenue indicates a service-oriented model with minimal fixed assets, which aligns with the labor-intensive nature of home health and pharmacy services. Investors should monitor goodwill for potential impairment triggers, especially if organic growth slows or reimbursement changes.

Retained Earnings Turn Positive

Retained earnings swung from -$246.1M in 2024Q1 to +$38.4M in 2026Q2, as reported in financial statements, marking a critical inflection point in equity quality.

The shift from accumulated deficits to positive retained earnings is a significant milestone, indicating that the company has generated enough cumulative profit to offset prior losses. This improvement is driven by the recent profitability turnaround, with net income turning positive in 2025. However, the equity base of $2.0B is still relatively small compared to total assets, and the company continues to use stock-based compensation, which dilutes shareholders. The positive retained earnings provide a cushion, but the equity quality remains dependent on sustained profitability.

Cash Buffer Strengthens, But Thin Margins

Cash surged to $550.4M in 2026Q2 from $58.0M in 2024Q1, with the current ratio improving to 1.59, according to recent filings, indicating a stronger liquidity position.

The liquidity position has improved markedly, with cash now covering a significant portion of short-term obligations. The current ratio of 1.59 is above the 1.0 threshold, suggesting adequate short-term solvency. However, the company's operating margins are razor-thin, and the cash balance may be needed for debt repayments or acquisitions, so the buffer is not excessive. The improvement in cash is partly due to working capital management and positive operating cash flow, but the sustainability of this liquidity depends on maintaining cash generation.

Goodwill Impairment Risk Looms

With goodwill of $2.5B representing 42% of assets and equity of only $2.0B, a 20% impairment would wipe out a quarter of equity, as per balance sheet data, posing a hidden risk.

The balance sheet is highly sensitive to goodwill impairment, given the large acquisition-related intangibles. If the company's market value declines or cash flow projections weaken, an impairment charge could significantly reduce equity and increase leverage. This risk is not apparent from the headline D/E ratio but is a material distortion. Investors should monitor the company's market capitalization relative to book value and any indicators of underperformance in acquired segments.

BTSG — Frequently Asked Questions

Quick answers to the most common questions about buying BTSG stock.

What are the total assets of BrightSpring Health Services, Inc. Common Stock (BTSG)?

As of 2025, BrightSpring Health Services, Inc. Common Stock (BTSG) had total assets of $6.41B including $2.89B in current assets.

How much debt does BrightSpring Health Services, Inc. Common Stock (BTSG) have?

BrightSpring Health Services, Inc. Common Stock (BTSG) carries total debt of $2.71B, offset by $88.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of BrightSpring Health Services, Inc. Common Stock?

BrightSpring Health Services, Inc. Common Stock (BTSG) has total shareholders' equity (book value) of $1.88B ($8.58 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is BrightSpring Health Services, Inc. Common Stock's current ratio and liquidity?

BrightSpring Health Services, Inc. Common Stock (BTSG) reported a current ratio of 1.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.